Related Experiment Video

Updated: Jun 4, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades

Jessica M Valdez1, Phillip Scheinberg, Olga Nunez

  • 1Howard Hughes Medical Institute, National Institutes of Health Research Scholars Program, National Heart, Lung and Blood Institute, Bethesda, Maryland, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|March 4, 2011
PubMed
Abstract

Insights

Advances in anti-infective therapy have significantly reduced infections and mortality in severe aplastic anemia (SAA) patients unresponsive to initial treatment. Survival rates have markedly improved over two decades due to better infection control and treatment strategies.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Persistent neutropenia in severe aplastic anemia (SAA) increases risk of life-threatening infections.
  • Invasive fungal infections (IFIs) historically associated with high mortality in SAA.
  • Limited data on current infection patterns and impact of new therapies in SAA.

Purpose of the Study:

  • To evaluate trends in infections, mortality, and survival in SAA patients unresponsive to initial immunosuppressive therapy (IST).
  • To assess the impact of evolving anti-infective strategies on patient outcomes over two decades.

Main Methods:

  • Retrospective review of 174 SAA patients unresponsive to IST at 6 months, admitted between 1989-2008.
  • Patients categorized into three groups based on IST protocol and time interval (1989-1996, 1996-2002, 2002-2008).
  • Analysis of infection patterns, resistance, survival rates, and infection-related mortality.

Main Results:

  • Infection-related mortality decreased from 37% to 11% (P < .001) and IFI frequency from 49% to 8% (P < .001) across the groups.
  • Overall 5-year survival increased from 64% to 79% (P < .001), and for non-responders from 23% to 57% (P < .001).
  • Younger age, higher neutrophil count, absence of IFIs, and voriconazole use predicted survival.

Conclusions:

  • Significant reductions in IFIs, infection-related mortality, and overall mortality observed in SAA patients over two decades.
  • Improved outcomes linked to advances in anti-infective therapies and treatment protocols.
  • SAA management has evolved, leading to better survival for refractory cases.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...